Sotiris Botozis Email & Phone Number

Canton Of Zug, Switzerland

Amsterdam Area

We are on a mission to redefine the commercialization of orphan medicines to improve patient access across Europe and beyond. Derived from the word ‘Tanzanite’ – one of the rarest and most underappreciated gemstones on earth – Avanzanite was formed to capitalize on two primary objectives, one economic, and one humanitarian. The economic goal is to offer end-to-end commercialization and distribution partnerships with research-based biopharmaceutical originators to unlock the full value of their orphan medicines in European markets. This is the unique expertise and core competency of our team following decades of operating experience navigating this area. Equally important, our humanitarian goals stem from our commitment to enabling access to novel medicines for patients who suffer from orphan diseases regardless of where in Europe they live. Avanzanite Bioscience B.V. is a fully authorized distributor of medicinal products within the European Economic Area, Switzerland and the UK.

Athens, Attiki, Greece

Anelixis is a company specialized in pharmaceutical promotion & partnering in Greece. On behalf of our clients, we build scalable, customized solutions that are on demand for small to multi-national organizations. Anelixis offers a capability-based model covering all aspects of product/portfolio management: patient-centric, pre-launch strategic positioning and planning, launch execution & delivery, digital & omni-channel transformation. At Anelixis, we are experts in the Greek healthcare market, with great exposure also to international environments. We can adapt our offering to perfectly match your current or future needs and strategic direction, representing your organization in the region and successfully commercializing your strategic life science assets.Anelixis and partners can offer innovative, end-to end solutions from early regulatory, pre-reimbursement and pre-launch to full portfolio representation & commercialization. We are also keen to meet and discuss commercialization partnerships with organizations planning to launch their assets in Greece.

Leading Astellas Pharma Commercial Operations (Hospital, Urology, Oncology & Hematology, Nephrology, Operational Excellence & Business Insights) in Greece, Cyprus & Malta

Remote

Member of Global Strategy Team, contributing to the launch of a new Nobel award winning molecule in Nephrology

Oncology/Hematology Business Unit Head (June 2012) - Bone Metabolism Business Unit Head (November 2009)

Allergy, Nootropics, GI

Mba International | Innovation & Entrepreneurship, Business Administration And Management, General

Bachelor Of Pharmacy - Bpharm, Pharmaceutical Sciences

Breakthrough Leadership (6 Mo.) - Amgen Sponsorship, Executive Leadership